An Activity-based Protein Profiling-supported Protein Therapeutic Drug discovery platform for the development of innovative anti-cancer therapies based on Lin28 inhibition

Project Information

ABPP-PROTDRUG

Grant agreement ID: 101022421

DOI

10.3030/101022421

Project closed

EC signature date 6 April 2021

Start date 1 September 2021

End date 30 September 2023

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost

€ 212 933,76

EU contribution

€ 212 933,76

Coordinated by

THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE
United Kingdom

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

The Impact of Activity-Based Protein Profiling in Malaria Drug Discovery

Author(s): Dr. Luís A. R. Carvalho, Prof. Gonçalo J. L. Bernardes
Published in: ChemMedChem, 2022, ISSN 1860-7179
Publisher: Wiley - V C H Verlag GmbbH & Co.
DOI: 10.1002/cmdc.202200174